Rocket Lab's $200M Quarter and $2.2B Backlog Fail to Stem Sell-Off as Blue Origin Blast and SpaceX IPO Jitters Trigger 15% Plunge

Rocket Lab posts record revenue and backlog, yet shares tumble 15% after Blue Origin test failure, insider sales, and SpaceX IPO uncertainty overshadow strong fundamentals.

Rocket Lab capped its strongest-ever quarter with revenue topping $200 million, a 63.5% surge from a year earlier, and a record order book worth $2.2 billion. Yet investors hit the eject button on June 1, sending shares down nearly 15% to $122.39 — a stark reminder that operational momentum can be overwhelmed by market forces.

The sell-off was driven by a triple blow: a Blue Origin engine test failure that rattled the entire space sector, insider sales totaling $18 million from four executives, and mounting uncertainty over the valuation of SpaceX’s upcoming initial public offering. The Nasdaq rose 0.21% that same day, underscoring the industry-specific nature of the rout.

Sector turbulence from a rival's mishap

Blue Origin’s New Glenn rocket exploded during a static-fire test at its Florida launch pad, generating seismic readings equivalent to a magnitude 2.5 earthquake. The shockwave rippled through space stocks — Rocket Lab, Planet Labs, and Intuitive Machines all closed lower, with Rocket Lab taking the hardest hit. Coming off a month where the stock had soared more than 50% and touched eight all-time highs, the technical overbought condition made it ripe for a pullback. Any excuse to book profits sufficed.

Inside the insider sales

Four insiders cashed out $18 million worth of shares at or near recent highs, intensifying the selling pressure. While insider sales are routine after extended rallies, the timing — just days before SpaceX is expected to price its landmark IPO — amplified the negative sentiment. The market interpreted the moves as a lack of conviction at the top, even though Rocket Lab’s operational story remains intact.

SpaceX IPO: valuation tug-of-war

SpaceX preparations have been a double-edged sword for Rocket Lab. For months, the prospect of Elon Musk’s rocket company listing on Nasdaq underpinned a sector-wide re-rating. Rocket Lab, one of the few publicly traded pure plays in launch services and satellite manufacturing, rode that wave to a 436% gain over twelve months. But the narrative is shifting. Reports now peg SpaceX’s targeted valuation at around $1.8 trillion — lower than the previously rumored $2 trillion-plus figure — and the formal marketing process is set to begin June 4, with pricing expected around June 11. As the IPO draws nearer, many institutional investors are rotating out of smaller names and into the direct SpaceX offering, pulling up the anchor for Rocket Lab’s stock.

Rocket Lab shares showed tentative recovery on June 2, rising 4.45 points to $126.84 by early afternoon, with volume already exceeding 6 million shares. The intraday range of $123.46 to $127.40 suggests buyers are stepping in, but the debate over fair value remains intense.

Record numbers, rising stakes

Against the market noise, Rocket Lab delivered first-quarter results that would normally spark celebration. Revenue hit $200.3 million, driven by 31 new Electron and HASTE launch contracts and five dedicated missions for the upcoming Neutron rocket. The backlog swelled to $2.2 billion. Management guided second-quarter revenue between $225 million and $240 million, with GAAP gross margins of 33% to 35% and an adjusted EBITDA loss of $20 million to $26 million.

Balance sheet strength is another pillar. After completing an at-the-market equity offering, Rocket Lab commands total liquidity exceeding $2 billion, including $1.205 billion in cash at the end of March. That financial runway covers development of the larger Neutron rocket, whose first flight is targeted for late 2026, as well as the ramp-up of launch cadence.

Defense contracts and robotics acquisition

On the pipeline front, the company recently passed a System Requirements Review for the Space Development Agency’s satellite program, pushing cumulative SDA contract value past $1.3 billion. Rocket Lab also closed the acquisition of Motiv Space Systems, a specialist in space robotics whose technology already flies on NASA’s Perseverance rover. The deal adds in-house capability for satellite servicing and in-space assembly.

The next operational milestone is the “The Grain Goddess Provides” mission, scheduled to launch as early as June from Rocket Lab’s New Zealand site. The payload is QPS-SAR-13, also known as MIKURA-I, a synthetic aperture radar satellite for Japanese customer iQPS. It marks the eighth launch for iQPS under a long-term contract covering 15 missions. The satellite will be deployed into a 575-kilometer circular orbit.

Valuation math under pressure

At roughly 48 times forward sales — well above the industry average — Rocket Lab’s valuation demands continued growth and a successful SpaceX IPO to act as a sector catalyst. Both assumptions are now in question. The stock is still up about 61% year to date and over 360% on a twelve-month basis, but the rapid correction highlights the fragility of momentum-driven multiples. Whether the company’s record backlog and expanding contract portfolio can anchor the share price as the sector recalibrates is the central question for investors in the weeks ahead.